Estrogen hormones reduce lipid peroxidation in cells and tissues of the central nervous system

Journal of Neurochemistry

Volumn 72, Issue 6, 1999, Pages 2531-2538

  Vedder, H ^a   Anthes, N ^a   Stumm, G ^a   Wurz C ^a   Behl, C ^b   Krieg, J C ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Brain; Estradiol; Neuron; Neuroprotection; Steroid

Indexed keywords

CORTICOSTERONE; ESTRADIOL; ESTROGEN; ESTRONE; PROGESTERONE; STEROID HORMONE; TESTOSTERONE;

ANIMAL CELL; ARTICLE; BRAIN PROTECTION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; ESTROGEN ACTIVITY; HIPPOCAMPUS; HORMONE ACTION; LIPID PEROXIDATION; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BRAIN; CELL SURVIVAL; CELLS, CULTURED; CORTICOSTERONE; ESTRADIOL; FERRIC COMPOUNDS; HUMANS; KINETICS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; NEOCORTEX; NEURONS; PROGESTERONE; RATS; RATS, WISTAR; TESTOSTERONE; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMIN E;

EID: 0033016186     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.0722531.x     Document Type: Article

References (43)

1. Ayres S., Baer J., and Subbiah M. T. (1998) Exercise-induced increase in lipid peroxidation parameters in amenorrheic female athletes. Fertil. Steril. 69, 73-77.
2. Behl C., Widmann M., Trapp T., and Holsboer F. (1995) 17β-Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem. Biophys. Res. Commun. 216, 473-482.
3. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C. J., and Holsboer F. (1997) Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol. Pharmacol. 51, 535-541.
4. Birge S. J. (1997) The role of estrogen in the treatment of Alzheimer's disease. Neurology 48 (Suppl. 7), 36-41.
5. Bondy S. C. (1995) The relation of oxidative stress and hyperexcitation to neurological disease. Proc. Soc. Exp. Biol. Med. 208, 337-345.
6. Cadenas E., Giensberg M., Rabe U., and Sies H. (1984) Evaluation of α-tocopherol antioxidant activity in microsomal lipid peroxidation as detected by low-level chemiluminescence. Biochem. J. 223, 755-759.
7. Coyle J. T. and Puttfarcken P. (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262, 689-695.
8. Davis J. B. and Maher P. (1994) Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652, 169-173.
9. Frölich L. and Riederer P. (1995) Free radical mechanisms in dementia of Alzheimer type and the potential for antioxidative treatment. Drug Res. 45, 443-446.
10. Gibbs R. B. (1994) Estrogen and nerve growth factor-related systems in brain. Effects on basal forebrain cholinergic neurons and implications for learning and memory processes and aging. Ann. NY Acad. Sci. 743, 165-196.
11. Green P. S., Gordon K., and Simpkins J. W. (1997) Phenolic A ring requirement for the neuroprotective effects of steroids. J. Steroid Biochem. Mol. Biol. 63, 229-235.
12. Gutteridge J. M. C. (1988) Lipid peroxidation: some problems and concepts, in Oxygen Radicals and Tissue Injury (Halliwell B., ed), pp. 9-19. Upjohn Co. and FASEB, Bethesda.
13. Häfner H., Behrens S., de Vry J., Gattaz W. F., Löffler W., Maurer K., and Riecher-Rössler A. (1991) Warum erkranken Frauen später an Schizophrenie? Erhöhung der Vulnerabilitätsschwelle durch Östrogene. Nervenheilk 10, 154-163.
14. Halliwell B. (1992) Oxygen radicals as key mediators in neurological disease; fact or fiction? Ann. Neurol. 32 (Suppl.), 10-15.
15. Halliwell B. and Gutteridge J. M. C. (1989) Free Radicals in Biology and Medicine, pp. 188-266. Oxford University Press, Oxford.
16. Halliwell B. and Gutteridge J. M. C. (1990) Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol. 186, 1-85.
17. Kawas C., Resnick S., Morrison A., Brookmeyer R., Corrada M., Zonderman A., Bacal C., Lingle D. D., and Metter E. (1997) A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore Longitudinal Study of Aging. Neurology 48, 1517-1521.
18. Komura B., Takahashi M., Morita T., Tsuchiya J., Arakawa Y., Yamamoto Y., and Niki E. (1990) Inhibition of peroxidations of lipids and membranes by estrogens. J. Phys. Org. Chem. 3, 309-315.
19. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
20. Miller C. P., Jirkovsky I., Hayhurst D. A., and Adelman S. J. (1996) In vitro antioxidant effects of estrogens with a hindered 3-OH function on the copper-induced oxidation of low density lipoprotein. Steroids 61, 305-308.
21. Monyer H., Hartley D. M., and Choi D. W. (1990) 21-Aminosteroids attenuate excitotoxic neuronal injury in cortical cell cultures. Neuron 5, 121-126.
22. Morimoto B. H. and Koshland D. E. (1990) Induction and expression of long- and short-term neurosecretory potentiation in a neural cell line. Neuron 5, 875-880.
23. Mosmann T. (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
24. Moss R. L., Gu Q., and Wong M. (1997) Estrogen: nontranscriptional signaling pathway. Recent Prog. Horm. Res. 52, 33-68.
25. Nohl H. (1993) Involvement of free radicals in ageing: a consequence or cause of senescence. Br. Med. Bull. 49, 653-667.
26. Ohkawa H., Oshishi N., and Yagi K. (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95, 351-358.
27. Olanow C. W. (1993) A radical hypothesis for neurodegeneration. Trends Neurosci. 16, 439-444.
28. Paganini-Hill A. and Henderson V. W. (1996) Estrogen replacement therapy and the risk of Alzheimer disease. Arch. Intern. Med. 156, 2213-2217.
29. Piotrowski J., Pietras T., Kurmanowska Z., Nowak D., Marczak J., Marks-Konczalik J., and Mazerant P. (1996) Effect of paraquat intoxication and ambroxol treatment on hydrogen peroxide production and lipid peroxidation in selected organs of the rat. J. Appl. Toxicol. 16, 501-507.
30. Ponglikitmongkol M., Green S., and Chambon P. (1988) Genomic organization of the human oestrogen receptor gene. EMBO J. 7, 3385-3388.
31. Roof R. L., Duvdevani R., and Stein D. G. (1993) Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res. 607, 333-336.
32. Ruiz-Larrea B., Leal A., Lacort M., and de Groot H. (1994) Antioxidant effects of estradiol and 2-hydroxyestradiol on iron-induced lipid peroxidation of rat liver microsomes. Steroids 59, 383-388.
33. Salminen A., Saari P., and Kihlström M. (1988) Age- and sex-related differences in lipid peroxidation of mouse cardiac and skeletal muscles. Comp. Biochem. Physiol 89, 695-699.
34. Sapolsky R. M. and Pulsinelli W. A. (1985) Glucocorticoids potentiate ischemic injury to neurons: therapeutic implications. Science 229, 1397-1400.
35. Schmidt R., Fazekas F., Reinhart B., Kapeller P., Fazekas G., Offenbacher H., Eber B., Schumacher M., and Friedl W. (1996) Estrogen replacement therapy in older women: a neuropsychological and brain MRI study. J. Am. Geriatr. Soc. 44, 1307-1313.
36. Sergeev P. V., Vladimirov Y. A., Seysfulla R. D., Denisov Y. P., and Rudnev Y. N. (1974) The role of chemical structure of steroid hormones in inhibition of peroxidative oxidation of lipids in mitochondrial membranes. Vopr. Med. Khim. 20, 359-362.
37. Subbarao K. V., Richardson J. S., and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
38. Sugioka K., Shimosegawa Y., and Nakano M. (1987) Estrogens as natural antioxidants of membrane phospholipid peroxidation. FEBS Lett. 210, 37-39.
39. Tang M. X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., and Mayeux R. (1996) Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 348, 429-432.
40. Vedder H., Weiß I., Holsboer F., and Reul J. M. H. M. (1993) Glucocorticoid and mineralocorticoid receptors in rat neocortical and hippocampal brain cells in culture: characterization and regulatory studies. Brain Res. 605, 18-24.
41. Wiesemann H. and Quinn P. (1994) The antioxidant action of synthetic estrogens involves increased membrane fluidity: relevance to their potential use as anticancer and cardioprotective agents compared to tamoxifen. Free Radic. Res. 21, 187-194.
42. Wilbur K. M., Bernheim F., and Shapiro O. W. (1949) Determination of lipid peroxidation. Arch. Biochem. 24, 305-310.
43. Youdim M. B. H., Ben-Shachar D., and Riederer P. (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8, 1-12.